Rockwell Medical director granted 9,633 RSUs

Nissenson Allen reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 07/06/2026 - 09:26 AM EDT

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Nissenson Allen reported acquisition or exercise transactions in this Form 4 filing.

ROCKWELL MEDICAL, INC. director Allen Nissenson received a grant of 9,633 shares of Common Stock as a compensation award, recorded at a price of $0.0000 per share. These shares are in the form of restricted stock units that vest on July 1, 2027, subject to his continued service through the 2027 annual meeting.

The company also completed a 1-for-10 reverse split of its common stock effective 12:01 a.m. on July 1, 2026, which reduced the number of shares held and adjusted outstanding equity awards. After these changes and the grant, Nissenson beneficially owns 23,892 shares directly.

Insider Trade Summary

Grant/Award: 9,633 shares

Grant/Award 1 txn

Insider Nissenson Allen

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	9,633	$0.00	$0.00

Holdings After Transaction: Common Stock — 23,892 shares (Direct)

Holdings Before and After: Common Stock, 14,259 to 23,892 shares (Direct)

Footnotes (2)

F1. Restricted stock units vest on July 1, 2027, subject to the Reporting Person's continued service to the Issuer through the 2027 Annual Meeting.
F2. Effective at 12:01 AM on July 1, 2026, the Issuer effected a 1-for-10 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, the shares listed under Amount of Securities Beneficially Owned Following Reported Transaction(s) reported in this Form 4 have been adjusted to reflect the 1-for-10 reverse split.

Key Figures

RSU grant size: 9,633 shares Grant price: $0.0000 per share Shares after transaction: 23,892 shares +2 more

5 metrics

RSU grant size 9,633 shares Restricted stock units granted to director Allen Nissenson

Grant price $0.0000 per share Stated price for the RSU grant

Shares after transaction 23,892 shares Beneficially owned following reported transaction(s)

Reverse split ratio 1-for-10 Reverse split of common stock effective July 1, 2026

Vesting date July 1, 2027 Vesting of restricted stock units, subject to continued service

Key Terms

Restricted stock units, reverse split, equity awards, beneficially owned

4 terms

Restricted stock units financial

"Restricted stock units vest on July 1, 2027, subject to the Reporting Person's continued service"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

reverse split financial

"the Issuer effected a 1-for-10 reverse split of the Issuer's common stock"

A reverse split is when a company reduces the number of its outstanding shares by combining several existing shares into one new share, so the price per share rises proportionally while the company’s overall value stays the same. Investors care because it can make a stock appear more respectable or meet exchange rules — like turning many small coins into a single larger bill — but it can also signal financial trouble and often affects trading liquidity and investor perception.

equity awards financial

"In addition, proportionate adjustments were made to the Issuer's outstanding equity awards."

Equity awards are payments to employees or directors made in the form of company stock or rights to buy stock later, serving as a way to share ownership rather than cash. For investors, they matter because they align staff incentives with company performance, can increase the number of shares outstanding over time (which can reduce each share’s claim on profits), and create compensation costs that affect reported earnings.

beneficially owned financial

"Amount of Securities Beneficially Owned Following Reported Transaction(s) reported in this Form 4"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Allen Nissenson acquire in the latest Rockwell Medical (RMTI) Form 4?

Allen Nissenson received 9,633 shares of Rockwell Medical Common Stock as a grant. The award is structured as restricted stock units that were granted at a stated price of $0.0000 per share and counts toward his overall beneficial ownership position.

When do Allen Nissenson’s new Rockwell Medical (RMTI) restricted stock units vest?

The restricted stock units vest on July 1, 2027, if Nissenson continues to serve the company through the 2027 annual meeting. This ties the equity compensation to ongoing board service over a multi‑year period before the shares become fully earned.

How many Rockwell Medical (RMTI) shares does Allen Nissenson own after this Form 4?

Following the reported grant and reverse split adjustment, Allen Nissenson beneficially owns 23,892 shares of Rockwell Medical Common Stock directly. This figure reflects both his prior holdings and the impact of the 1‑for‑10 reverse stock split on his equity position.

What reverse stock split did Rockwell Medical (RMTI) implement affecting this Form 4?

Rockwell Medical effected a 1‑for‑10 reverse split of its common stock effective 12:01 a.m. on July 1, 2026. This reduced the number of shares outstanding and proportionately adjusted existing equity awards, including the amounts reported as beneficially owned by Allen Nissenson.

Is Allen Nissenson’s Rockwell Medical (RMTI) Form 4 a market purchase or a grant?

The transaction is a grant, coded as an “A” transaction for a grant, award, or other acquisition. Nissenson did not buy shares in the open market; instead he received 9,633 restricted stock units as part of his equity compensation package.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Nissenson Allen

(Last)

(First)

(Middle)

C/O ROCKWELL MEDICAL, INC.

30142 WIXOM ROAD

(Street)

WIXOM

MICHIGAN

48393

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ROCKWELL MEDICAL, INC. [ RMTI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	07/01/2026		A⁽¹⁾		9,633	A	$0	23,892⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Restricted stock units vest on July 1, 2027, subject to the Reporting Person's continued service to the Issuer through the 2027 Annual Meeting.

2. Effective at 12:01 AM on July 1, 2026, the Issuer effected a 1-for-10 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, the shares listed under Amount of Securities Beneficially Owned Following Reported Transaction(s) reported in this Form 4 have been adjusted to reflect the 1-for-10 reverse split.

Remarks:

	/s/ Megan Timmins, Attorney-in-Fact for Allen R. Nissenson	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR